Form 4 for EHC Encompass Health Corp
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001127602-24-007557 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-29 | 2024-02-28 | EHC | Tarr Mark J | Pres, CEO, Dir | A - Grant | $0.00 | +89.5K | 539.3K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Encompass Health Common Stock | 2024-02-28 | A | A | 14,789 | $0.00 | 554,098 | D | — | — | (F2) Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. |
| 2 | Common | Encompass Health Common Stock | 2024-02-28 | A | A | 74,711 | $0.00 | 539,309 | D | — | — | (F1) This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 25, 2022. |